Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial

Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial

Abstract Background Fibrotic interstitial lung diseases (ILDs) are chronic and often progressive conditions resulting in substantial morbidity and mortality. Shortness of breath, a symptom often linked to oxygen desaturation on exertion, is tightly linked to worsening quality of life in these patien...

Full description

Bibliographic Details
Main Authors: Dina Visca, Vicky Tsipouri, Letizia Mori, Ashi Firouzi, Sharon Fleming, Morag Farquhar, Elizabeth Leung, Toby M. Maher, Paul Cullinan, Nick Hopkinson, Athol U. Wells, Winston Banya, Jennifer A. Whitty, Huzaifa Adamali, Lisa G. Spencer, Piersante Sestini, Elisabetta A. Renzoni
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Trials
Subjects:
Fibrotic interstitial lung disease
Ambulatory oxygen
Oxygen desaturation
Health status
Quality of life
Activity measures
Online Access:http://link.springer.com/article/10.1186/s13063-017-1912-9

Internet

http://link.springer.com/article/10.1186/s13063-017-1912-9

Similar Items